CD36, a lipid-associated transmembrane protein involved in FAs recognition and translocation, has been linked to tumor progression via EMT in various cancers, though its role in CRC remains unclear [41, 42, 57–59]. The gene discussed is CD36; the disease is colorectal carcinoma.